Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation

Journal of Heart and Lung Transplantation

Volumn 30, Issue 2, 2011, Pages 164-174

  Schaffer, Justin M ^a   Allen, Jeremiah G ^a   Weiss, Eric S ^a   Arnaoutakis, George J ^a   Patel, Nishant D ^a   Russell, Stuart D ^a   Shah, Ashish S ^a   Conte, John V ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

heart failure; infectious complications; LVAD; mechanical circulatory support; sepsis

Indexed keywords

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CONTINUOUS FLOW; CONTROLLED STUDY; DEVICE INFECTION; DISEASE SEVERITY; FLOW KINETICS; HEART ASSIST DEVICE; HUMAN; IMPLANTATION; INFECTION RISK; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PULSATILE FLOW; RISK ASSESSMENT; SCORING SYSTEM; SEATTLE HEART FAILURE MODEL SCORE; SEPSIS; SEPTIC SHOCK; SURGICAL RISK; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADULT; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SHOCK, SEPTIC; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 78650948706     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.08.003     Document Type: Article

References (35)

1. W.L. Holman, S.J. Park, and J.W. Long Infection in permanent circulatory support: experience from the REMATCH trial J Heart Lung Transplant 23 2004 1359 1365
2. K. Lietz, J.W. Long, and A.G. Kfoury Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection Circulation 116; 2007 497 505
3. L.W. Miller, F.D. Pagani, and S.D. Russell Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
4. M.S. Slaughter, J.G. Rogers, and C.A. Milano Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
5. R.J. Gordon, B. Quagliarello, and F.D. Lowy Ventricular assist device-related infections Lancet Infect Dis 6 2006 426 437
6. M. Argenziano, K.A. Catanese, and N. Moazami The influence of infection on survival and successful transplantation in patients with left ventricular assist devices J Heart Lung Transplant 16 1997 822 831
7. S.M. Gordon, S.K. Schmitt, and M. Jacobs Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Ann Thorac Surg 72 2001 725 730
8. P.N. Malani, D.B. Dyke, and F.D. Pagani Nosocomial infections in left ventricular assist device recipients Clin Infect Dis 34 2002 1295 1300
9. D. Simon, S. Fischer, and A. Grossman Left ventricular assist device-related infection: treatment and outcome Clin Infect Dis 40 2005 1108 1115
10. A. Zierer, S.J. Melby, and R.K. Voeller Late-onset driveline infections: the achilles' heel of prolonged left ventricular assist device support Ann Thorac Surg 84 2007 515 521
11. W.L. Holman, B.K. Rayburn, and D.C. McGiffin Infection in ventricular assist devices: prevention and treatment Ann Thorac Surg 75 suppl 2003 S48 S57
12. D.N. Helman, and M.C. Oz Developing a comprehensive mechanical support program J Card Surg 16 2001 203 208
13. W.A. Knaus, E.A. Draper, and D.P. Wagner APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
14. W.A. Knaus, J.E. Zimmerman, and D.P. Wagner APACHEacute physiology and chronic health evaluation: a physiologically based classification system Crit Care Med 9 1981 591 597
15. N. Gracin, M.R. Johnson, and D. Spokas The use of APACHE II scores to select candidates for left ventricular assist device placement: acute physiology and chronic health evaluation J Heart Lung Transplant 17 1998 1017 1023
16. W.C. Levy, D. Mozaffarian, and D.T. Linker The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 21; 2006 113 :1424-33
17. W.C. Levy, D. Mozaffarian, and D.T. Linker Can the Seattle Heart Failure Model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant 28 2009 231 236
18. J.K. Kirklin, D.C. Naftel, and L.W. Stevenson INTERMACS database for durable devices for circulatory support: first annual report J Heart Lung Transplant 27 2008 1065 1072
19. V. Rao, M.C. Oz, and M.A. Flannery Revised screening scale to predict survival after insertion of a left ventricular assist device J Thorac Cardiovasc Surg 125 2003 855 862
20. K. Lietz, J.W. Long, and A.G. Kfoury Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection Circulation 116 2007 497 505
21. J.M. Schaffer, J.G. Allen, and E.S. Weiss Evaluation of risk indices in continuous-flow left ventricular assist device patients Ann Thorac Surg 88 2009 1889 1896
22. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 1992 864 874
23. L.G. Reimer, M.P. Weinstein, and M.L. Wilson Update on the detection of bacteremia and fungemia Clin Microbiol Rev 10 1997 444 465
24. L.G. Bekeris, J.A. Tworek, and M.K. Walsh Trends in blood culture contamination: a College of American Pathologists Q-Tracks Study of 356 institutions Arch Pathol Lab Med 129 2005 1222 1225
25. A.J. Mangram, T.C. Horan, and M.L. Pearson Guideline for prevention of surgical site infection, 1999 Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee Am J Infect Control 27 1999 97 132
26. N.P. O'Grady, M. Alexander, and E.P. Dellinger Guidelines for the prevention of intravascular catheter-related infections MMWR Recomm Rep 51 2002 1 28
27. O.C. Tablan, L.J. Anderson, and R. Besser Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee MMWR Recomm Rep 26; 2004 53 1-36
28. J. Pugin, R. Auckenthaler, and N. Mili Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid Am Rev Respir Dis 143 1991 1121 1129
29. T.M. Hooton, S.F. Bradley, and D.D. Cardenas Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America Clin Infect Dis 50 2010 625 663
30. D.R. Cox Regression models and life tables J R Stat Soc B34 1972 187 220
31. W.L. Holman, S.V. Pamboukian, and M. Blood Managing device infections: are we progressing or is infection an insurmountable obstacle? ASAIO J 51 2005 452 455
32. S.M. Berenholtz, P.J. Pronovost, and P.A. Lipsett Eliminating catheter-related bloodstream infections in the intensive care unit Crit Care Med 32 2004 2014 2020
33. R.S. Poston, S. Husain, and D. Sorce LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD Infection J Heart Lung Transplant 22 2003 914 921
34. A.V. Kalya, A.J. Tector, and J.D. Crouch Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution J Heart Lung Transplant 24 2005 1973 1975
35. M. Haddad, P.J. Hendry, and R.G. Masters Ventricular assist devices as a bridge to cardiac transplantation: the Ottawa experience Artif Organs 28 2004 136 141